Robert J. Bitterman
CIK: 0001304395
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Phio Pharmaceuticals Corp.
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Sep 28, 2026PHIO
Phio Pharmaceuticals Corp.
Award(A)Direct400K shares- - Sep 22, 2026PHIO
Phio Pharmaceuticals Corp.
Purchase(P)Direct2K shares at avg. $1.03$2K - Sep 11, 2026PHIO
Phio Pharmaceuticals Corp.
Tax Payment(F)Direct68.6K shares at avg. $1.03$71K - Aug 18, 2026PHIO
Phio Pharmaceuticals Corp.
Purchase(P)Direct10K shares at avg. $1.06$11K - Jun 26, 2026PHIO
Phio Pharmaceuticals Corp.
Purchase(P)Direct10K shares at avg. $0.99$10K - Feb 5, 2026PHIO
Phio Pharmaceuticals Corp.
Award(A)Direct120K shares- - Dec 31, 2025PHIO
Phio Pharmaceuticals Corp.
Purchase(P)Direct5K shares at avg. $1.03$5K - Dec 23, 2025PHIO
Phio Pharmaceuticals Corp.
Purchase(P)Direct5K shares at avg. $1.02$5K - Nov 21, 2025PHIO
Phio Pharmaceuticals Corp.
Purchase(P)Direct5K shares at avg. $1.14$6K - Nov 18, 2025PHIO
Phio Pharmaceuticals Corp.
Purchase(P)Direct5K shares at avg. $1.27$6K - Sep 11, 2025PHIO
Phio Pharmaceuticals Corp.
Award(A)Direct250K shares- - Sep 11, 2025PHIO
Phio Pharmaceuticals Corp.
Tax Payment(F)Direct4.1K shares at avg. $2.32$10K - Jun 10, 2025PHIO
Phio Pharmaceuticals Corp.
Purchase(P)Direct2K shares at avg. $2.42$5K - Jun 9, 2025PHIO
Phio Pharmaceuticals Corp.
Purchase(P)Direct1.5K shares at avg. $2.75$4K - May 22, 2025PHIO
Phio Pharmaceuticals Corp.
Purchase(P)Direct1.2K shares at avg. $1.78$2K - May 21, 2025PHIO
Phio Pharmaceuticals Corp.
Purchase(P)Direct3K shares at avg. $1.77$5K - Sep 11, 2024PHIO
Phio Pharmaceuticals Corp.
Award(A)Direct15.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 28, 2026 | PHIO Phio Pharmaceuticals Corp. | Award(A) | 400,000 | - | $0 | Direct |
| Sep 22, 2026 | PHIO Phio Pharmaceuticals Corp. | Purchase(P) | 2,000 | $1.03 | $2,058 | Direct |
| Sep 11, 2026 | PHIO Phio Pharmaceuticals Corp. | Tax Payment(F) | 68,550 | $1.03 | $70,607 | Direct |
| Aug 18, 2026 | PHIO Phio Pharmaceuticals Corp. | Purchase(P) | 10,000 | $1.06 | $10,600 | Direct |
| Jun 26, 2026 | PHIO Phio Pharmaceuticals Corp. | Purchase(P) | 10,000 | $0.99 | $9,900 | Direct |
| Feb 5, 2026 | PHIO Phio Pharmaceuticals Corp. | Award(A) | 120,000 | - | $0 | Direct |
| Dec 31, 2025 | PHIO Phio Pharmaceuticals Corp. | Purchase(P) | 5,000 | $1.03 | $5,150 | Direct |
| Dec 23, 2025 | PHIO Phio Pharmaceuticals Corp. | Purchase(P) | 5,000 | $1.02 | $5,100 | Direct |
| Nov 21, 2025 | PHIO Phio Pharmaceuticals Corp. | Purchase(P) | 5,000 | $1.14 | $5,700 | Direct |
| Nov 18, 2025 | PHIO Phio Pharmaceuticals Corp. | Purchase(P) | 5,000 | $1.27 | $6,350 | Direct |
| Sep 11, 2025 | PHIO Phio Pharmaceuticals Corp. | Award(A) | 250,000 | - | - | Direct |
| Sep 11, 2025 | PHIO Phio Pharmaceuticals Corp. | Tax Payment(F) | 4,111 | $2.32 | $9,538 | Direct |
| Jun 10, 2025 | PHIO Phio Pharmaceuticals Corp. | Purchase(P) | 2,000 | $2.42 | $4,840 | Direct |
| Jun 9, 2025 | PHIO Phio Pharmaceuticals Corp. | Purchase(P) | 1,500 | $2.75 | $4,125 | Direct |
| May 22, 2025 | PHIO Phio Pharmaceuticals Corp. | Purchase(P) | 1,200 | $1.78 | $2,136 | Direct |
| May 21, 2025 | PHIO Phio Pharmaceuticals Corp. | Purchase(P) | 3,000 | $1.77 | $5,310 | Direct |
| Sep 11, 2024 | PHIO Phio Pharmaceuticals Corp. | Award(A) | 15,500 | - | $0 | Direct |
1-17 of 17 transactions
About Bitterman Robert J
Bitterman Robert J (SEC CIK 0001304395) files insider reports with the SEC as Chairman, Pres. & CEO of Phio Pharmaceuticals Corp. (PHIO).
Signal8 holds 15 ownership filings by Bitterman Robert J, all Form 4s, filed between Sep 13, 2024 and Sep 29, 2026. Those filings report 17 transactions, from Sep 11, 2024 to Sep 28, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Bitterman Robert J's filings is in KING OF PRUSSIA, PA.
Recent filings by Bitterman Robert J
- Sep 28, 2026: Grant or award of PHIO shares (Form 4, code A).
- Sep 22, 2026: Open-market purchase of PHIO shares (Form 4, code P).
- Sep 11, 2026: Tax withholding of PHIO shares (Form 4, code F).
- Aug 18, 2026: Open-market purchase of PHIO shares (Form 4, code P).
- Jun 26, 2026: Open-market purchase of PHIO shares (Form 4, code P).
Other insiders filing for Phio Pharmaceuticals Corp. (PHIO)
- Carson Lisa Cabott, Chief Financial Officer
- Plott Ronald Todd, Director
- BRADFORD PATRICIA A, Director
- Lockshin Curtis, Director
- Freeman Jonathan E, Director
- Deming David H, Director